Deciphering apicoplast function during blood stage Plasmodium infection

破译血液阶段疟原虫感染期间的顶质体功能

• 批准号: 8443797
• 负责人: Ellen Yeh
• 金额: $ 13.32万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-03-15 至 2017-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8443797
• 关键词: Advisory Committees; Anabolism; Antimalarials; Apicomplexa; Appointment; Artemisinins; Biology; Blood; Chemicals; Clinical Pathology; Combined Modality Therapy; Communicable Diseases; Complex; Computer Simulation; Culicidae; Development; Development Plans; Doctor of Philosophy; Drug Targeting; Erythrocytes; Future; Genomics; Goals; Growth; Human; Infection; International; Investigation; Knowledge; Label; Life Cycle Stages; Malaria; Mass Spectrum Analysis; Mentors; Metabolic; Metabolic Pathway; Organelles; Outcome; Output; Parasites; Parasitology; Pathogenesis; Pathologist; Pathway interactions; Pharmaceutical Preparations; Pharmacotherapy; Plasmodium; Plasmodium falciparum; Plastids; Preparation; Principal Investigator; Proteins; Research; Research Personnel; Residencies; Resistance development; Role; Staging; Technology; Training; artemisinine; base; career; career development; drug development; innovation; interest; intrahepatic; isoprenoid; microbial; novel; research and development; symposium; therapeutic development; therapeutic target; vaccine development

DESCRIPTION (provided by applicant): Malaria caused by Plasmodium spp parasites is a leading infectious disease killer in the developing world. In the face of developing resistance against the current last-line therapy, new antimalarials are desperately needed and a greater understanding of Plasmodium biology will be required to identify viable therapeutic targets. The apicoplast, a unique prokaryotically-derived plastid organelle found in Plasmodium, holds promise for both drug and vaccine development as it is essential for every stage in the parasite's complex life cycle. Yet despite its importance to parasite survival and the identification of several biosynthetic pathways in the organelle, the function of the apicoplast during infection remains unclear. Our long-term objective is to identify the specific proteins and pathways involved in apicoplast function for therapeutic and vaccine development. The goal of this proposal is to decipher the role of the apicoplast-located isoprenoid precursor biosynthetic pathway in blood-stage P. falciparum infection. This pathway is of particular interest because it 1) is prokaryotic and therefore not found in the human host, 2) may be essential for blood-stage growth, 3) may be the only cytoplasmic metabolite derived from the apicoplast during blood stage growth, and 4) is required for the biosynthesis of cellular isoprenoids with a host of potential downstream functions that could be unique to the parasite. The specific aims are: 1) to determine the essentiality and sufficiency of isoprenoid precursor biosynthesis for fulfilling apicoplast function during blood-stage infection and 2) to identify the cellular isoprenoids derived from isoprenoid precursors during blood stage infection. We propose innovative chemical biology approaches to probe the function of this pathway. The outcome of these aims will represent a significant advance in our understanding of isoprenoid precursor biosynthesis in apicoplast function and blood-stage P. falciparum infection. This knowledge has the potential to reveal novel aspects of Plasmodium pathogenesis and facilitate identification of specific candidates for antimalarial drug development. The proposed research is part of a mentored career development plan for an academic career in microbial pathogenesis and parasitology. The principal investigator is a PhD-trained biochemist/chemical biologist and infectious disease pathologist completing Clinical Pathology residency training. My goal as an independent researcher is to apply chemical biology approaches to the study of malaria pathogenesis. Dr. Joe DeRisi, who has been at the forefront of the application of genomic technology to the study of Plasmodium biology, will serve as a mentor for this project. The career development plan also includes the appointment of an advisory committee, classes and seminars in microbial pathogenesis, and presentation at international malaria conferences. The proposed research and career development activities will be critical in the preparation for an academic career and provide ample opportunities for a future in independent research.

描述（由申请人提供）：由疟原虫属寄生虫引起的疟疾是发展中国家的主要传染病杀手。面对对当前最后一线疗法产生的耐药性，迫切需要新的抗疟药，并且需要对疟原虫生物学有更深入的了解，以确定可行的治疗靶点。顶端质体是在疟原虫中发现的一种独特的原核来源的质体细胞器，它对药物和疫苗的开发都有希望，因为它对于寄生虫复杂生命周期的每个阶段都至关重要。然而，尽管顶质体对于寄生虫的生存和细胞器中几种生物合成途径的识别很重要，但其在感染过程中的功能仍不清楚。我们的长期目标是确定参与顶质体功能的特定蛋白质和途径，用于治疗和疫苗开发。该提案的目标是破译位于顶端体的类异戊二烯前体生物合成途径在血液阶段恶性疟原虫感染中的作用。该途径特别令人感兴趣，因为它 1) 是原核生物，因此在人类宿主中未发现，2) 可能对血液阶段生长至关重要，3) 可能是血液阶段生长期间源自顶质体的唯一细胞质代谢产物，并且4) 是细胞类异戊二烯生物合成所必需的，具有寄生虫特有的许多潜在下游功能。具体目标是：1) 确定类异戊二烯前体生物合成对于在血液阶段感染期间实现顶端质体功能的必要性和充分性；2) 鉴定在血液阶段感染期间源自类异戊二烯前体的细胞类异戊二烯。我们提出创新的化学生物学方法来探索该途径的功能。这些目标的结果将代表我们对类异戊二烯前体生物合成在顶端体功能和血液阶段恶性疟原虫感染中的理解取得了重大进展。这些知识有可能揭示疟原虫发病机制的新方面，并有助于识别抗疟药物开发的特定候选药物。拟议的研究是微生物发病机制和寄生虫学学术职业指导职业发展计划的一部分。主要研究者是一位受过博士学位的生物化学家/化学生物学家和传染病病理学家，完成了临床病理学住院医师培训。作为一名独立研究人员，我的目标是将化学生物学方法应用于疟疾发病机制的研究。 Joe DeRisi 博士一直处于将基因组技术应用于疟原虫生物学研究的前沿，他将担任该项目的导师。职业发展计划还包括任命咨询委员会、微生物发病机制课程和研讨会以及在国际疟疾会议上的演讲。拟议的研究和职业发展活动对于学术生涯的准备至关重要，并为未来的独立研究提供充足的机会。